لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: González-de-Olano D; Department of Allergy, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain.; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Salamanca, Spain., Navarro-Navarro P; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Salamanca, Spain.; Department of Medicine and Citometry Service (NUCLEUS), Cancer Research Center (IBMCC, USAL-CSIC), Universidad de Salamanca, Salamanca, Spain.; Sequencing Service (NUCLEUS), Universidad de Salamanca, Salamanca, Spain., Muñoz-González JI; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Salamanca, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain., Sánchez-Muñoz L; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Salamanca, Spain.; Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast), Virgen del Valle Hospital, Toledo, Spain., Henriques A; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Salamanca, Spain.; Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast), Virgen del Valle Hospital, Toledo, Spain., de-Andrés-Martín A; Department of Immunology, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain., Peralta-Arjonilla D; Department of Immunology, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain., Mayado A; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Salamanca, Spain.; Department of Medicine and Citometry Service (NUCLEUS), Cancer Research Center (IBMCC, USAL-CSIC), Universidad de Salamanca, Salamanca, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., Jara-Acevedo M; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Salamanca, Spain.; Sequencing Service (NUCLEUS), Universidad de Salamanca, Salamanca, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., García-Montero AC; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Salamanca, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., Orfao A; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Salamanca, Spain.; Department of Medicine and Citometry Service (NUCLEUS), Cancer Research Center (IBMCC, USAL-CSIC), Universidad de Salamanca, Salamanca, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., Álvarez-Twose I; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Salamanca, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain.; Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast), Virgen del Valle Hospital, Toledo, Spain.

المصدر: Allergy [Allergy] 2024 Mar; Vol. 79 (3), pp. 711-723. Date of Electronic Publication: 2023 Oct 11.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 7804028 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1398-9995 (Electronic) Linking ISSN: 01054538 NLM ISO Abbreviation: Allergy Subsets: MEDLINE

مواضيع طبية MeSH: Anaphylaxis*/epidemiology , Anaphylaxis*/genetics , Anaphylaxis*/diagnosis , Mastocytosis*/diagnosis , Mastocytosis*/epidemiology , Mastocytosis*/genetics , Mast Cell Activation Syndrome*, Humans ; Mast Cells ; Tryptases/genetics ; Genotype

SCR Disease Name: Hereditary alpha-tryptasemia syndrome

المؤلفون: Rama TA; Serviço de Imunoalergologia, Centro Hospitalar Universitário São João, Porto, Portugal; Serviço de Imunologia Básica e Clínica, Departamento de Patologia, Faculdade de Medicina da Universidade do Porto, Porto, Portugal; EPIUnit - Institute of Public Health, University of Porto, Porto, Portugal; Laboratory for Integrative and Translational Research in Population Health (ITR), Porto, Portugal. Electronic address: tarama@med.up.pt., Henriques AF; Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast) - Reference Center (CSUR) for Mastocytosis, Hospital Virgen del Valle, Complejo Hospitalario Universitario de Toledo, Toledo, Spain; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Spain., Matito A; Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast) - Reference Center (CSUR) for Mastocytosis, Hospital Virgen del Valle, Complejo Hospitalario Universitario de Toledo, Toledo, Spain; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Spain., Jara-Acevedo M; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Spain; DNA Sequencing Service (NUCLEUS), Instituto de Investigación Biomédica de Salamanca (IBSAL), University of Salamanca, Salamanca, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Caldas C; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Spain; DNA Sequencing Service (NUCLEUS), Instituto de Investigación Biomédica de Salamanca (IBSAL), University of Salamanca, Salamanca, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Mayado A; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain; Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine, Cytometry Service (NUCLEUS) Instituto de Investigación Biomédica de Salamanca (IBSAL), University of Salamanca, Salamanca, Spain., Muñoz-González JI; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain; Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine, Cytometry Service (NUCLEUS) Instituto de Investigación Biomédica de Salamanca (IBSAL), University of Salamanca, Salamanca, Spain., Moreira A; Serviço de Imunoalergologia, Centro Hospitalar Universitário São João, Porto, Portugal; Serviço de Imunologia Básica e Clínica, Departamento de Patologia, Faculdade de Medicina da Universidade do Porto, Porto, Portugal; EPIUnit - Institute of Public Health, University of Porto, Porto, Portugal; Laboratory for Integrative and Translational Research in Population Health (ITR), Porto, Portugal., Cavaleiro-Rufo J; EPIUnit - Institute of Public Health, University of Porto, Porto, Portugal; Laboratory for Integrative and Translational Research in Population Health (ITR), Porto, Portugal., García-Montero A; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain; Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine, Cytometry Service (NUCLEUS) Instituto de Investigación Biomédica de Salamanca (IBSAL), University of Salamanca, Salamanca, Spain., Órfão A; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain; Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine, Cytometry Service (NUCLEUS) Instituto de Investigación Biomédica de Salamanca (IBSAL), University of Salamanca, Salamanca, Spain., Sanchez-Muñoz L; Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast) - Reference Center (CSUR) for Mastocytosis, Hospital Virgen del Valle, Complejo Hospitalario Universitario de Toledo, Toledo, Spain; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Spain., Álvarez-Twose I; Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast) - Reference Center (CSUR) for Mastocytosis, Hospital Virgen del Valle, Complejo Hospitalario Universitario de Toledo, Toledo, Spain; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.

المصدر: The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2023 May; Vol. 11 (5), pp. 1536-1547. Date of Electronic Publication: 2023 Feb 18.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101597220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-2201 (Electronic) NLM ISO Abbreviation: J Allergy Clin Immunol Pract Subsets: MEDLINE

مواضيع طبية MeSH: Cytokines*/blood , Mastocytosis, Systemic*/blood , Mastocytosis, Systemic*/complications , Mastocytosis, Systemic*/immunology , Bone Remodeling*/immunology , Bone Resorption*/etiology , Osteosclerosis*/complications, Biomarkers/blood ; Humans ; Male ; Female ; Adolescent ; Young Adult ; Adult ; Middle Aged ; Aged

المؤلفون: Pérez-Pons A; Cancer Research Center (IBMCC, USAL-CSIC) Department of Medicine and Cytometry Service (NUCLEUS) Universidad de Salamanca Salamanca Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain.; Biomedical Research Institute of Salamanca Salamanca Spain.; Spanish Network on Mastocytosis (REMA) Toledo and Salamanca Spain., Jara-Acevedo M; Cancer Research Center (IBMCC, USAL-CSIC) Department of Medicine and Cytometry Service (NUCLEUS) Universidad de Salamanca Salamanca Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain.; Biomedical Research Institute of Salamanca Salamanca Spain.; Spanish Network on Mastocytosis (REMA) Toledo and Salamanca Spain.; Sequencing Service (NUCLEUS) Universidad de Salamanca Salamanca Spain., Henriques A; Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain.; Spanish Network on Mastocytosis (REMA) Toledo and Salamanca Spain.; Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast) Virgen del Valle Hospital Toledo Spain., Navarro-Navarro P; Cancer Research Center (IBMCC, USAL-CSIC) Department of Medicine and Cytometry Service (NUCLEUS) Universidad de Salamanca Salamanca Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain.; Biomedical Research Institute of Salamanca Salamanca Spain.; Spanish Network on Mastocytosis (REMA) Toledo and Salamanca Spain.; Sequencing Service (NUCLEUS) Universidad de Salamanca Salamanca Spain., García-Montero AC; Cancer Research Center (IBMCC, USAL-CSIC) Department of Medicine and Cytometry Service (NUCLEUS) Universidad de Salamanca Salamanca Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain.; Biomedical Research Institute of Salamanca Salamanca Spain.; Spanish Network on Mastocytosis (REMA) Toledo and Salamanca Spain., Álvarez-Twose I; Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain.; Spanish Network on Mastocytosis (REMA) Toledo and Salamanca Spain.; Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast) Virgen del Valle Hospital Toledo Spain., Pedreira CE; Systems and Computing Department (PESC) COPPE Federal University of Rio de Janeiro (UFRJ) Rio de Janeiro Brazil., Sánchez-Muñoz L; Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain.; Spanish Network on Mastocytosis (REMA) Toledo and Salamanca Spain.; Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast) Virgen del Valle Hospital Toledo Spain., Damasceno D; Cancer Research Center (IBMCC, USAL-CSIC) Department of Medicine and Cytometry Service (NUCLEUS) Universidad de Salamanca Salamanca Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain.; Biomedical Research Institute of Salamanca Salamanca Spain., Caldas C; Cancer Research Center (IBMCC, USAL-CSIC) Department of Medicine and Cytometry Service (NUCLEUS) Universidad de Salamanca Salamanca Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain.; Biomedical Research Institute of Salamanca Salamanca Spain.; Spanish Network on Mastocytosis (REMA) Toledo and Salamanca Spain., Muñoz-González JI; Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain.; Spanish Network on Mastocytosis (REMA) Toledo and Salamanca Spain.; Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast) Virgen del Valle Hospital Toledo Spain., Matito A; Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain.; Spanish Network on Mastocytosis (REMA) Toledo and Salamanca Spain.; Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast) Virgen del Valle Hospital Toledo Spain., Flores-Montero J; Cancer Research Center (IBMCC, USAL-CSIC) Department of Medicine and Cytometry Service (NUCLEUS) Universidad de Salamanca Salamanca Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain.; Biomedical Research Institute of Salamanca Salamanca Spain., González-López O; Cancer Research Center (IBMCC, USAL-CSIC) Department of Medicine and Cytometry Service (NUCLEUS) Universidad de Salamanca Salamanca Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain.; Biomedical Research Institute of Salamanca Salamanca Spain.; Spanish Network on Mastocytosis (REMA) Toledo and Salamanca Spain., Criado I; Cancer Research Center (IBMCC, USAL-CSIC) Department of Medicine and Cytometry Service (NUCLEUS) Universidad de Salamanca Salamanca Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain.; Biomedical Research Institute of Salamanca Salamanca Spain., Mayado A; Cancer Research Center (IBMCC, USAL-CSIC) Department of Medicine and Cytometry Service (NUCLEUS) Universidad de Salamanca Salamanca Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain.; Biomedical Research Institute of Salamanca Salamanca Spain.; Spanish Network on Mastocytosis (REMA) Toledo and Salamanca Spain., Orfao A; Cancer Research Center (IBMCC, USAL-CSIC) Department of Medicine and Cytometry Service (NUCLEUS) Universidad de Salamanca Salamanca Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain.; Biomedical Research Institute of Salamanca Salamanca Spain.; Spanish Network on Mastocytosis (REMA) Toledo and Salamanca Spain.

المصدر: Clinical and translational allergy [Clin Transl Allergy] 2022 Jun 14; Vol. 12 (6), pp. e12167. Date of Electronic Publication: 2022 Jun 14 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 101576043 Publication Model: eCollection Cited Medium: Print ISSN: 2045-7022 (Print) Linking ISSN: 20457022 NLM ISO Abbreviation: Clin Transl Allergy Subsets: PubMed not MEDLINE

المؤلفون: González-López O; Cancer Research Center (IBMCC, USAL/CSIC), Department of Medicine, Universidad de Salamanca, Biomedical Research Institute of Salamanca and Spanish Network on Mastocytosis (REMA), 37007 Salamanca, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029 Madrid, Spain., Muñoz-González JI; Cancer Research Center (IBMCC, USAL/CSIC), Department of Medicine, Universidad de Salamanca, Biomedical Research Institute of Salamanca and Spanish Network on Mastocytosis (REMA), 37007 Salamanca, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029 Madrid, Spain., Orfao A; Cancer Research Center (IBMCC, USAL/CSIC), Department of Medicine, Universidad de Salamanca, Biomedical Research Institute of Salamanca and Spanish Network on Mastocytosis (REMA), 37007 Salamanca, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029 Madrid, Spain., Álvarez-Twose I; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029 Madrid, Spain.; Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast, Virgen del Valle Hospital) and REMA, 45071 Toledo, Spain., García-Montero AC; Cancer Research Center (IBMCC, USAL/CSIC), Department of Medicine, Universidad de Salamanca, Biomedical Research Institute of Salamanca and Spanish Network on Mastocytosis (REMA), 37007 Salamanca, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029 Madrid, Spain.

المصدر: Cancers [Cancers (Basel)] 2022 May 18; Vol. 14 (10). Date of Electronic Publication: 2022 May 18.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: Henriques A; Instituto de Estudios de Mastocitosis de Castilla La Mancha, Virgen del Valle Hospital, Toledo, Spain.; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain., Muñoz-González JI; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain.; Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytometry Service, NUCLEUS, University of Salamanca, Salamanca, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain; and., Sánchez-Muñoz L; Instituto de Estudios de Mastocitosis de Castilla La Mancha, Virgen del Valle Hospital, Toledo, Spain.; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain., Matito A; Instituto de Estudios de Mastocitosis de Castilla La Mancha, Virgen del Valle Hospital, Toledo, Spain.; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain., Torres-Rivera L; Instituto de Estudios de Mastocitosis de Castilla La Mancha, Virgen del Valle Hospital, Toledo, Spain., Jara-Acevedo M; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain; and.; Sequencing Service, NUCLEUS, University of Salamanca, Salamanca, Spain., Caldas C; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain.; Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytometry Service, NUCLEUS, University of Salamanca, Salamanca, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain; and., Mayado A; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain.; Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytometry Service, NUCLEUS, University of Salamanca, Salamanca, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain; and., Pérez-Pons A; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain.; Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytometry Service, NUCLEUS, University of Salamanca, Salamanca, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain; and., García-Montero AC; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain.; Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytometry Service, NUCLEUS, University of Salamanca, Salamanca, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain; and., Álvarez-Twose I; Instituto de Estudios de Mastocitosis de Castilla La Mancha, Virgen del Valle Hospital, Toledo, Spain.; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain., Orfao A; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain.; Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytometry Service, NUCLEUS, University of Salamanca, Salamanca, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain; and.

المصدر: Blood [Blood] 2022 Jan 27; Vol. 139 (4), pp. 572-583.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Mast Cells/*pathology , Mastocytosis/*diagnosis , Neoplastic Cells, Circulating/*pathology, Adult ; Aged ; Aged, 80 and over ; Antigens, CD34/analysis ; Female ; Humans ; Male ; Mastocytosis/blood ; Middle Aged ; Prognosis ; Young Adult

المؤلفون: Muñoz-González JI; Cancer Research Center (The Institute of Cancer Molecular and Cellular Biology, Universidad de Salamanca-Consejo Superior de Investigaciones Científicas), Department of Medicine and Cytometry Service (NUCLEUS), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), University of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Spain., García-Montero AC; Cancer Research Center (The Institute of Cancer Molecular and Cellular Biology, Universidad de Salamanca-Consejo Superior de Investigaciones Científicas), Department of Medicine and Cytometry Service (NUCLEUS), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), University of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Spain., Orfao A; Cancer Research Center (The Institute of Cancer Molecular and Cellular Biology, Universidad de Salamanca-Consejo Superior de Investigaciones Científicas), Department of Medicine and Cytometry Service (NUCLEUS), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), University of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Spain., Álvarez-Twose I; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Spain; Instituto de Estudios de Mastocitosis de Castilla-La Mancha (CLMast)-Spanish Reference Center (CSUR) for Mastocytosis and CIBERONC, Virgen del Valle Hospital, Complejo Hospitalario Universitario de Toledo, Toledo, Spain. Electronic address: ivana@sescam.jccm.es.

المصدر: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology [Ann Allergy Asthma Immunol] 2021 Oct; Vol. 127 (4), pp. 427-434. Date of Electronic Publication: 2021 Jul 20.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: American College of Allergy, Asthma, and Immunology Country of Publication: United States NLM ID: 9503580 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4436 (Electronic) Linking ISSN: 10811206 NLM ISO Abbreviation: Ann Allergy Asthma Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Inflammation Mediators/*metabolism , Mast Cells/*immunology , Mastocytosis, Systemic/*genetics , Mastocytosis, Systemic/*pathology , Proto-Oncogene Proteins c-kit/*genetics , Tryptases/*genetics, Anaphylaxis/pathology ; Frameshift Mutation/genetics ; Humans ; Mastocytosis, Systemic/immunology ; Point Mutation/genetics ; Protein Domains/genetics

المؤلفون: López-Sánchez J; Department of General and Gastrointestinal Surgery, Pancreas Transplant Program, Hospital Universitario de Salamanca, Salamanca, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Universidad de Salamanca, Salamanca, Spain., Esteban C; Department of General and Gastrointestinal Surgery, Pancreas Transplant Program, Hospital Universitario de Salamanca, Salamanca, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Universidad de Salamanca, Salamanca, Spain., Iglesias MJ; Department of General and Gastrointestinal Surgery, Pancreas Transplant Program, Hospital Universitario de Salamanca, Salamanca, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Universidad de Salamanca, Salamanca, Spain., González LM; Department of General and Gastrointestinal Surgery, Pancreas Transplant Program, Hospital Universitario de Salamanca, Salamanca, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Universidad de Salamanca, Salamanca, Spain., Quiñones JE; Department of General and Gastrointestinal Surgery, Pancreas Transplant Program, Hospital Universitario de Salamanca, Salamanca, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Universidad de Salamanca, Salamanca, Spain., González-Muñoz JI; Department of General and Gastrointestinal Surgery, Pancreas Transplant Program, Hospital Universitario de Salamanca, Salamanca, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Universidad de Salamanca, Salamanca, Spain., Tabernero G; Department of Nephrology, Hospital Universitario de Salamanca, Salamanca, Spain., Iglesias RA; Department of Endocrinology, Hospital Universitario de Salamanca, Salamanca, Spain., Fraile P; Department of Nephrology, Hospital Universitario de Salamanca, Salamanca, Spain., Muñoz-González JI; Biomedical Research Institute of Salamanca (IBSAL), Universidad de Salamanca, Salamanca, Spain.; Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytometry Service (NUCLEUS), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Universidad de Salamanca, Salamanca, Spain., Muñoz-Bellvís L; Department of General and Gastrointestinal Surgery, Pancreas Transplant Program, Hospital Universitario de Salamanca, Salamanca, Spain. luismb@usal.es.; Biomedical Research Institute of Salamanca (IBSAL), Universidad de Salamanca, Salamanca, Spain. luismb@usal.es.; Department of Surgery, Hospital Universitario de Salamanca, Paseo San Vicente, 88-132, 37007, Salamanca, Spain. luismb@usal.es.

المصدر: Langenbeck's archives of surgery [Langenbecks Arch Surg] 2021 May; Vol. 406 (3), pp. 873-882. Date of Electronic Publication: 2021 Jan 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 9808285 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1435-2451 (Electronic) Linking ISSN: 14352443 NLM ISO Abbreviation: Langenbecks Arch Surg Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus* , Kidney Transplantation*, Cross-Sectional Studies ; Humans ; Pancreas ; Quality of Life

المؤلفون: Muñoz-González JI; Cancer Research Center-IBMCC-USAL-CSIC, Department of Medicine and Cytometry Service-Nucleus Platform, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), University of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain., Álvarez-Twose I; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain; Instituto de Estudios de Mastocitosis de Castilla La Mancha and CIBERONC, Virgen del Valle Hospital, Toledo, Spain., Jara-Acevedo M; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain; Sequencing Service-Nucleus Platform, CIBERONC, University of Salamanca and IBSAL, Salamanca, Spain., Zanotti R; Section of Hematology, Department of Medicine, Verona University Hospital, Verona, Italy., Perkins C; Division of Hematology, Department of Medicine, Stanford University School of Medicine and Stanford Cancer Institute, Stanford, CA, USA., Jawhar M; Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany., Sperr WR; Department of Internal Medicine I, Division of Hematology and Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Shoumariyeh K; Department of Medicine I, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium Partner Site Freiburg and German Cancer Research Center, Heidelberg, Germany., Schwaab J; Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany., Greiner G; Department of Laboratory Medicine and Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Henriques A; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain; Instituto de Estudios de Mastocitosis de Castilla La Mancha and CIBERONC, Virgen del Valle Hospital, Toledo, Spain., Caldas C; Cancer Research Center-IBMCC-USAL-CSIC, Department of Medicine and Cytometry Service-Nucleus Platform, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), University of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain., Fernández-Giménez C; Cancer Research Center-IBMCC-USAL-CSIC, Department of Medicine and Cytometry Service-Nucleus Platform, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), University of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain., Sánchez-Muñoz L; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain; Instituto de Estudios de Mastocitosis de Castilla La Mancha and CIBERONC, Virgen del Valle Hospital, Toledo, Spain., Mayado A; Cancer Research Center-IBMCC-USAL-CSIC, Department of Medicine and Cytometry Service-Nucleus Platform, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), University of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain., Pérez-Pons A; Cancer Research Center-IBMCC-USAL-CSIC, Department of Medicine and Cytometry Service-Nucleus Platform, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), University of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain., Schmitt-Graeff A; Albert Ludwig University of Freiburg, Freiburg, Germany., Duyster J; Department of Medicine I, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium Partner Site Freiburg and German Cancer Research Center, Heidelberg, Germany., Tanasi I; Section of Hematology, Department of Medicine, Verona University Hospital, Verona, Italy., Olivieri F; Allergy Unit, Verona University Hospital, Verona, Italy., Mora-Casterá E; Hospital Universitario y Politécnico de la Fe, Valencia, Spain., Luna I; Hospital Universitario y Politécnico de la Fe, Valencia, Spain., Senent L; Hospital Universitario y Politécnico de la Fe, Valencia, Spain., Bañas MH; Hospital San Pedro Alcantara, Cáceres, Spain., Nuñez-García A; Hospital Virgen de las Nieves, Granada, Spain., Jurado-Chacón M; Genomic Oncology Area, Centre for Genomics and Oncological Research, Pfizer-University of Granada-Andalusian Regional Government, Granada, Spain; Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain; Instituto de Investigación Biosanitaria de Granada, Complejo Hospitales Universitarios de Granada, Universidad de Granada, Granada, Spain., Martín-Sánchez G; Hospital Universitario Marqués de Valdecilla, Santander, Spain., Colado E; Hospital Universitario Central de Asturias, Oviedo, Spain., Xicoy B; Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Badalona, Spain; Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona., Gener-Ricós G; Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Badalona, Spain; Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona., Gotlib J; Division of Hematology, Department of Medicine, Stanford University School of Medicine and Stanford Cancer Institute, Stanford, CA, USA., Bonadonna P; Allergy Unit, Verona University Hospital, Verona, Italy., Reiter A; Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany., Valent P; Department of Internal Medicine I, Division of Hematology and Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., García-Montero AC; Cancer Research Center-IBMCC-USAL-CSIC, Department of Medicine and Cytometry Service-Nucleus Platform, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), University of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain., Orfao A; Cancer Research Center-IBMCC-USAL-CSIC, Department of Medicine and Cytometry Service-Nucleus Platform, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), University of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain. Electronic address: orfao@usal.es.

المصدر: The Lancet. Haematology [Lancet Haematol] 2021 Mar; Vol. 8 (3), pp. e194-e204. Date of Electronic Publication: 2021 Jan 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Mastocytosis, Systemic/*diagnosis, Adult ; Aged ; Alkaline Phosphatase/blood ; Core Binding Factor Alpha 2 Subunit/genetics ; Female ; Hemoglobins/analysis ; Humans ; Kaplan-Meier Estimate ; Male ; Mastocytosis, Systemic/mortality ; Middle Aged ; Polymorphism, Single Nucleotide ; Prognosis ; Progression-Free Survival ; Repressor Proteins/genetics ; Retrospective Studies ; Risk Factors ; Serine-Arginine Splicing Factors/genetics

المؤلفون: Galatà G; School of Medicine, University of Southampton, Southampton SO17 1BJ, UK., García-Montero AC; Institute of Biomedical Research of Salamanca, Salamanca 37007, Spain; Servicio de Citometría, Departamento de Medicina, CIBERONC, and Instituto de Biología Molecular y Celular del Cáncer, CSIC/Universidad de Salamanca, Salamanca 37007, Spain., Kristensen T; Department of Pathology, Odense University Hospital, 5000 Odense, Denmark; Mastocytosis Centre Odense University Hospital, 5000 Odense, Denmark., Dawoud AAZ; School of Medicine, University of Southampton, Southampton SO17 1BJ, UK., Muñoz-González JI; Institute of Biomedical Research of Salamanca, Salamanca 37007, Spain; Servicio de Citometría, Departamento de Medicina, CIBERONC, and Instituto de Biología Molecular y Celular del Cáncer, CSIC/Universidad de Salamanca, Salamanca 37007, Spain., Meggendorfer M; Munich Leukemia Laboratory, 81377 Munich, Germany., Guglielmelli P; Centro di Ricerca e Innovazione per le Malattie Mieloproliferative, Azienda Ospedaliera Universitaria Careggi, Dipartimento di Medicina Sperimentale e Clinica, Università Degli Studi di Firenze, 50134 Firenze, Italy., Hoade Y; School of Medicine, University of Southampton, Southampton SO17 1BJ, UK., Alvarez-Twose I; Instituto de Mastocitosis de Castilla La Mancha, Hospital Virgen del Valle, 45071 Toledo, Spain., Gieger C; Institute of Genetic Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany; German Centre for Cardiovascular Research Partner Site Munich Heart Alliance, 80802 Munich, Germany; Research Unit of Molecular Epidemiology, Helmholtz Zentrum München, Germany Research Center for Environmental Health, 85764 Neuherberg, Germany; German Center for Diabetes Research, 85764 Neuherberg, Germany., Strauch K; Institute of Genetic Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany; Chair of Genetic Epidemiology, IBE, Faculty of Medicine, LMU Munich, 80539 Munich, Germany; Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Johannes Gutenberg University, 55131 Mainz, Germany., Ferrucci L; Longitudinal study section, Translation Gerontology Branch, National Institute on Aging, Baltimore, MD 21224, USA., Tanaka T; Longitudinal study section, Translation Gerontology Branch, National Institute on Aging, Baltimore, MD 21224, USA., Bandinelli S; Geriatric Unit, Azienda USL Toscana centro, 50137 Firenze, Italy., Schnurr TM; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark., Haferlach T; Munich Leukemia Laboratory, 81377 Munich, Germany., Broesby-Olsen S; Mastocytosis Centre Odense University Hospital, 5000 Odense, Denmark; Department of Dermatology and Allergy Centre, Odense University Hospital, 5000 Odense, Denmark; Odense Research Center for Anaphylaxis, Odense University Hospital, 5000 Odense, Denmark., Vestergaard H; Mastocytosis Centre Odense University Hospital, 5000 Odense, Denmark; Department of Hematology, Odense University Hospital, 5000 Odense, Denmark., Møller MB; Department of Pathology, Odense University Hospital, 5000 Odense, Denmark; Mastocytosis Centre Odense University Hospital, 5000 Odense, Denmark., Bindslev-Jensen C; Mastocytosis Centre Odense University Hospital, 5000 Odense, Denmark; Department of Dermatology and Allergy Centre, Odense University Hospital, 5000 Odense, Denmark; Odense Research Center for Anaphylaxis, Odense University Hospital, 5000 Odense, Denmark., Vannucchi AM; Centro di Ricerca e Innovazione per le Malattie Mieloproliferative, Azienda Ospedaliera Universitaria Careggi, Dipartimento di Medicina Sperimentale e Clinica, Università Degli Studi di Firenze, 50134 Firenze, Italy., Orfao A; Institute of Biomedical Research of Salamanca, Salamanca 37007, Spain; Servicio de Citometría, Departamento de Medicina, CIBERONC, and Instituto de Biología Molecular y Celular del Cáncer, CSIC/Universidad de Salamanca, Salamanca 37007, Spain., Radia D; Department of Clinical Haematology, Guy's and St Thomas' NHS Hospitals, London SE1 9RT, UK., Reiter A; University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany., Chase AJ; School of Medicine, University of Southampton, Southampton SO17 1BJ, UK; Wessex Regional Genetics Laboratory, Salisbury NHS Foundation Trust, Salisbury SP2 8BJ, UK., Cross NCP; School of Medicine, University of Southampton, Southampton SO17 1BJ, UK; Wessex Regional Genetics Laboratory, Salisbury NHS Foundation Trust, Salisbury SP2 8BJ, UK. Electronic address: ncpc@soton.ac.uk., Tapper WJ; School of Medicine, University of Southampton, Southampton SO17 1BJ, UK.

المصدر: American journal of human genetics [Am J Hum Genet] 2021 Feb 04; Vol. 108 (2), pp. 284-294. Date of Electronic Publication: 2021 Jan 08.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 0370475 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-6605 (Electronic) Linking ISSN: 00029297 NLM ISO Abbreviation: Am J Hum Genet Subsets: MEDLINE

مواضيع طبية MeSH: Genetic Predisposition to Disease* , Genome-Wide Association Study* , Polymorphism, Single Nucleotide*, Mastocytosis/*genetics , Proto-Oncogene Proteins c-kit/*genetics, Amino Acid Transport System y+/genetics ; CCAAT-Enhancer-Binding Proteins/genetics ; DNA, Intergenic ; Female ; Humans ; Interleukin-13/genetics ; Introns ; Male ; RNA, Long Noncoding/genetics ; Receptors, Cytoplasmic and Nuclear/genetics ; Repressor Proteins/genetics ; Telomerase/genetics ; Tryptases/genetics